Genmab (GMAB) has an average rating of Buy and mean price target of $37.62, according to analysts polled by FactSet.
What else is happening in Research?
Research
Janney Downgrades Wintrust Financial to Neutral From Buy, $170 Price Target
Wintrust Financial (WTFC) has an average rating of overweight and mean price target of $176.85, according to analysts polled by FactSet.Price: $157.24, Change: $-6.42, Percent Change: -3.93%
$WTFC
Research
Northland Securities Downgrades Calix to Outperform From Market Perform, Price Target $52
Northland Securities Downgrades Calix to Outperform From Market Perform, Price Target $52
$CALX
Research
Jefferies Downgrades UTZ Brands to Hold From Buy, $14.25 Price Target
UTZ Brands (UTZ) has an average rating of overweight and mean price target of $12.95, according to analysts polled by FactSet.Price: $14.07, Change: $+6.62, Percent Change: +88.86%
$UTZ